Cargando…

Efficacy and Safety of Janus Kinase Inhibitors in Type I Interferon-Mediated Monogenic Autoinflammatory Disorders: A Scoping Review

IMPORTANCE: Type I interferon (IFN)-mediated monogenic autoinflammatory disorders (interferonopathies) are childhood-onset rare multisystemic diseases with limited treatment options. The Janus kinase (JAK) inhibitors are promising potential therapeutic candidates for immune-mediated chronic inflamma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gómez-Arias, Pedro Jesús, Gómez-García, Francisco, Hernández-Parada, Jorge, Montilla-López, Ana María, Ruano, Juan, Parra-Peralbo, Esmeralda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163936/ https://www.ncbi.nlm.nih.gov/pubmed/33856640 http://dx.doi.org/10.1007/s13555-021-00517-9

Ejemplares similares

A Scoping Review on Use of Drugs Targeting the JAK/STAT Pathway in Psoriasis
por: Gómez-García, Francisco, et al.
Publicado: (2022)

Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
por: Montilla, Ana M., et al.
Publicado: (2019)

The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases
por: Gaggiano, Carla, et al.
Publicado: (2022)

Dermatologic and Dermatopathologic Features of Monogenic Autoinflammatory Diseases
por: Figueras-Nart, Ignasi, et al.
Publicado: (2019)

Interferon in systemic lupus erythematosus—A halfway between monogenic autoinflammatory and autoimmune disease
por: Saulescu, Ioana, et al.
Publicado: (2022)

The expanding spectrum of rare monogenic autoinflammatory diseases
por: Touitou, Isabelle, et al.
Publicado: (2013)

Biochemistry of Autoinflammatory Diseases: Catalyzing Monogenic Disease
por: Beck, David B., et al.
Publicado: (2019)

The classification, genetic diagnosis and modelling of monogenic autoinflammatory disorders
por: Moghaddas, Fiona, et al.
Publicado: (2018)

Monogenic Autoinflammatory Diseases: State of the Art and Future Perspectives
por: Di Donato, Giulia, et al.
Publicado: (2021)

VEXAS syndrome: an adult-onset monogenic autoinflammatory disease with many unanswered questions
por: Hernández-Rodríguez, José, et al.
Publicado: (2023)

Biological Treatments: New Weapons in the Management of Monogenic Autoinflammatory Disorders
por: Vitale, Antonio, et al.
Publicado: (2013)

Management of Monogenic IL-1 Mediated Autoinflammatory Diseases in Childhood
por: Welzel, Tatjana, et al.
Publicado: (2021)

Biological therapies in monogenic autoinflammatory diseases: long-term efficacy and safety
por: Pelagatti, Maria A, et al.
Publicado: (2014)

Monogenic Autoinflammatory Syndromes: State of the Art on Genetic, Clinical, and Therapeutic Issues
por: Caso, Francesco, et al.
Publicado: (2013)

Altered cytokine pattern and inflammatory pathways in monogenic and complex autoinflammatory diseases
por: Galozzi, P, et al.
Publicado: (2015)

Hints for Genetic and Clinical Differentiation of Adult-Onset Monogenic Autoinflammatory Diseases
por: Gaggiano, Carla, et al.
Publicado: (2019)

A Pro-Inflammatory Signature Constitutively Activated in Monogenic Autoinflammatory Diseases
por: Galozzi, Paola, et al.
Publicado: (2022)

Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review
por: Gómez-García, Francisco, et al.
Publicado: (2019)

Monogenic Autoinflammatory Diseases with Mendelian Inheritance: Genes, Mutations, and Genotype/Phenotype Correlations
por: Martorana, Davide, et al.
Publicado: (2017)

The Many Faces of a Monogenic Autoinflammatory Disease: Adenosine Deaminase 2 Deficiency
por: Kendall, Jennifer Lee, et al.
Publicado: (2020)

VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases
por: Vitale, Antonio, et al.
Publicado: (2023)

Monogenic and multifactorial autoinflammatory diseases: Clinical and laboratory characterization in a pediatric Saudi population
por: Al-Mayouf, S, et al.
Publicado: (2015)

Monogenic autoinflammatory diseases in children: single center experience with clinical, genetic, and imaging review
por: Alsharief, Alaa N., et al.
Publicado: (2020)

Interleukin 1 inhibitors in monogenic autoinflammatory diseases – one size does not fit all
por: Więsik-Szewczyk, Ewa
Publicado: (2021)

Prevalence of monogenic autoinflammatory diseases among Pediatric Rheumatology centers: the Eurofever PReS/PRINTO survey
por: Gattorno, M, et al.
Publicado: (2008)

The Central Role of Anti-IL-1 Blockade in the Treatment of Monogenic and Multi-Factorial Autoinflammatory Diseases
por: Federici, Silvia, et al.
Publicado: (2013)

Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases
por: Bettiol, Alessandra, et al.
Publicado: (2019)

Single-Center Overview of Pediatric Monogenic Autoinflammatory Diseases in the Past Decade: A Summary and Beyond
por: Wang, Wei, et al.
Publicado: (2020)

Drosophila Lipophorin Receptors Mediate the Uptake of Neutral Lipids in Oocytes and Imaginal Disc Cells by an Endocytosis-Independent Mechanism
por: Parra-Peralbo, Esmeralda, et al.
Publicado: (2011)

Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide
por: Soriano, Alessandra, et al.
Publicado: (2020)

Origin and Development of the Adipose Tissue, a Key Organ in Physiology and Disease
por: Parra-Peralbo, Esmeralda, et al.
Publicado: (2021)

Efficacy and safety of thalidomide in children with monogenic autoinflammatory diseases: a single-center, real-world-evidence study
por: Zhang, Caihui, et al.
Publicado: (2023)

Central nervous system manifestations of monogenic autoinflammatory disorders and the neurotropic features of SARS-CoV-2: Drawing the parallels
por: Renson, Thomas, et al.
Publicado: (2022)

Pathophysiology, clinical manifestations and current management of IL-1 mediated monogenic systemic autoinflammatory diseases, a literature review
por: Li, Yandie, et al.
Publicado: (2022)

The Janus kinases (Jaks)
por: Yamaoka, Kunihiro, et al.
Publicado: (2004)

Janus Kinases in Leukemia
por: Raivola, Juuli, et al.
Publicado: (2021)

Monogenic autoinflammatory diseases in adults – a challenge to rheumatologic practice at the onset of the Polish national programme of interleukin 1 inhibitor treatment
por: Milchert, Marcin, et al.
Publicado: (2019)

STAT and Janus kinase targeting by human herpesvirus 8 interferon regulatory factor in the suppression of type-I interferon signaling
por: Xiang, Qiwang, et al.
Publicado: (2022)

Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies
por: Kim, Hanna, et al.
Publicado: (2020)

Stratification of patients with autoinflammatory phenotypes by interferon (IFN) score suggests a new group of IFN mediated autoinflammatory diseases with overlapping clinical phenotypes
por: de Jesus, A Almeida, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8256okmtq7h3qfh22mqaelhp66